25 XP   0   0   10

Telo Genomics Corp
Buy, Hold or Sell?

Let's analyse Telo Genomics Corp together

PenkeI guess you are interested in Telo Genomics Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Telo Genomics Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Telo Genomics Corp

I send you an email if I find something interesting about Telo Genomics Corp.

Quick analysis of Telo Genomics Corp (30 sec.)










What can you expect buying and holding a share of Telo Genomics Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.02
Expected worth in 1 year
$0.01
How sure are you?
31.3%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-2.7%

For what price can you sell your share?

Current Price per Share
$0.14
Expected price per share
$0.09 - $0.192
How sure are you?
50%

1. Valuation of Telo Genomics Corp (5 min.)




Live pricePrice per Share (EOD)

$0.14

Intrinsic Value Per Share

$-0.48 - $-0.56

Total Value Per Share

$-0.46 - $-0.55

2. Growth of Telo Genomics Corp (5 min.)




Is Telo Genomics Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2m$2.3m-$689k-41.7%

How much money is Telo Genomics Corp making?

Current yearPrevious yearGrowGrow %
Making money-$560.5k-$441.9k-$118.6k-21.2%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Telo Genomics Corp (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#127 / 145

Most Revenue
#142 / 145

Most Profit
#71 / 145

What can you expect buying and holding a share of Telo Genomics Corp? (5 min.)

Welcome investor! Telo Genomics Corp's management wants to use your money to grow the business. In return you get a share of Telo Genomics Corp.

What can you expect buying and holding a share of Telo Genomics Corp?

First you should know what it really means to hold a share of Telo Genomics Corp. And how you can make/lose money.

Speculation

The Price per Share of Telo Genomics Corp is $0.1433. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Telo Genomics Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Telo Genomics Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.02. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Telo Genomics Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-6.0%-0.01-5.5%-0.01-4.3%0.00-3.3%-0.01-4.1%
Usd Book Value Change Per Share-0.01-7.6%0.00-0.7%-0.01-5.3%0.001.0%0.000.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-7.6%0.00-0.7%-0.01-5.3%0.001.0%0.000.4%
Usd Price Per Share0.14-0.19-0.27-0.20-0.20-
Price to Earnings Ratio-4.10--6.16--11.07--12.22--9.34-
Price-to-Total Gains Ratio-12.89--12.76--36.48--11.12--9.72-
Price to Book Ratio8.28-9.99-8.54-7.99-6.96-
Price-to-Total Gains Ratio-12.89--12.76--36.48--11.12--9.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1433
Number of shares6978
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (6978 shares)-6.829.51
Gains per Year (6978 shares)-27.2738.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-27-3703828
20-55-6407666
30-82-910114104
40-109-1180152142
50-136-1450190180
60-164-1720228218
70-191-1990266256
80-218-2260304294
90-245-2530342332
100-273-2800380370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.029.03.00.0%0.029.03.00.0%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%6.014.00.030.0%10.022.00.031.3%10.022.00.031.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.032.00.0%0.00.032.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%6.014.00.030.0%10.022.00.031.3%10.022.00.031.3%

Fundamentals of Telo Genomics Corp

About Telo Genomics Corp

Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides TeloView-SMM application; TeloView, an analysis software platform for prediction of genomic instability. It has a collaboration agreement with the Mayo Clinic to validate its SMM tests for multiple myeloma. Telo Genomics Corp. is headquartered in Toronto, Canada.

Fundamental data was last updated by Penke on 2024-04-20 04:37:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Telo Genomics Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Telo Genomics Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Telo Genomics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.7%+6.7%
TTM--6.7%+6.7%
YOY-0.3%-0.3%
5Y--1.5%+1.5%
10Y--3.4%+3.4%
1.1.2. Return on Assets

Shows how efficient Telo Genomics Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • -39.9% Return on Assets means that Telo Genomics Corp generated $-0.40 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Telo Genomics Corp:

  • The MRQ is -39.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -34.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-39.9%TTM-34.1%-5.8%
TTM-34.1%YOY-19.2%-14.9%
TTM-34.1%5Y-21.9%-12.2%
5Y-21.9%10Y-31.0%+9.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.9%-1.3%-38.6%
TTM-34.1%-1.3%-32.8%
YOY-19.2%-0.9%-18.3%
5Y-21.9%-0.5%-21.4%
10Y-31.0%-0.9%-30.1%
1.1.3. Return on Equity

Shows how efficient Telo Genomics Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • -50.5% Return on Equity means Telo Genomics Corp generated $-0.51 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Telo Genomics Corp:

  • The MRQ is -50.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -40.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-50.5%TTM-40.7%-9.8%
TTM-40.7%YOY-20.8%-19.9%
TTM-40.7%5Y-19.9%-20.8%
5Y-19.9%10Y-22.9%+3.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-50.5%-0.5%-50.0%
TTM-40.7%--40.7%
YOY-20.8%0.3%-21.1%
5Y-19.9%-1.4%-18.5%
10Y-22.9%-2.3%-20.6%

1.2. Operating Efficiency of Telo Genomics Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Telo Genomics Corp is operating .

  • Measures how much profit Telo Genomics Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Telo Genomics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.2%+6.2%
TTM-0.5%-0.5%
YOY-4.0%-4.0%
5Y-3.7%-3.7%
10Y--1.3%+1.3%
1.2.2. Operating Ratio

Measures how efficient Telo Genomics Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Telo Genomics Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.280-1.280
TTM-1.304-1.304
YOY-1.236-1.236
5Y-1.242-1.242
10Y-1.205-1.205

1.3. Liquidity of Telo Genomics Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Telo Genomics Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 5.07 means the company has $5.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Telo Genomics Corp:

  • The MRQ is 5.068. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.413. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.068TTM8.413-3.345
TTM8.413YOY28.033-19.621
TTM8.4135Y16.757-8.344
5Y16.75710Y11.239+5.518
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0682.111+2.957
TTM8.4132.298+6.115
YOY28.0332.599+25.434
5Y16.7573.012+13.745
10Y11.2393.081+8.158
1.3.2. Quick Ratio

Measures if Telo Genomics Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.24 means the company can pay off $0.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Telo Genomics Corp:

  • The MRQ is 0.242. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.273. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.242TTM0.273-0.030
TTM0.273YOY0.469-0.197
TTM0.2735Y0.358-0.086
5Y0.35810Y0.289+0.069
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2421.204-0.962
TTM0.2731.319-1.046
YOY0.4691.602-1.133
5Y0.3581.943-1.585
10Y0.2892.203-1.914

1.4. Solvency of Telo Genomics Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Telo Genomics Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Telo Genomics Corp to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.21 means that Telo Genomics Corp assets are financed with 21.0% credit (debt) and the remaining percentage (100% - 21.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Telo Genomics Corp:

  • The MRQ is 0.210. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.146. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.210TTM0.146+0.064
TTM0.146YOY0.072+0.075
TTM0.1465Y0.730-0.584
5Y0.73010Y0.803-0.072
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2100.429-0.219
TTM0.1460.407-0.261
YOY0.0720.394-0.322
5Y0.7300.450+0.280
10Y0.8030.450+0.353
1.4.2. Debt to Equity Ratio

Measures if Telo Genomics Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 26.7% means that company has $0.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Telo Genomics Corp:

  • The MRQ is 0.267. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.175. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.267TTM0.175+0.092
TTM0.175YOY0.078+0.097
TTM0.1755Y0.147+0.027
5Y0.14710Y0.331-0.184
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2670.606-0.339
TTM0.1750.571-0.396
YOY0.0780.631-0.553
5Y0.1470.658-0.511
10Y0.3310.735-0.404

2. Market Valuation of Telo Genomics Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Telo Genomics Corp generates.

  • Above 15 is considered overpriced but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • A PE ratio of -4.10 means the investor is paying $-4.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Telo Genomics Corp:

  • The EOD is -4.193. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.096. Based on the earnings, the company is expensive. -2
  • The TTM is -6.155. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.193MRQ-4.096-0.097
MRQ-4.096TTM-6.155+2.059
TTM-6.155YOY-11.065+4.910
TTM-6.1555Y-12.224+6.069
5Y-12.22410Y-9.339-2.884
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-4.193-0.235-3.958
MRQ-4.096-0.395-3.701
TTM-6.155-0.284-5.871
YOY-11.0650.002-11.067
5Y-12.2244.834-17.058
10Y-9.3395.200-14.539
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Telo Genomics Corp:

  • The EOD is -3.742. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.656. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.933. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.742MRQ-3.656-0.086
MRQ-3.656TTM-4.933+1.276
TTM-4.933YOY-9.174+4.242
TTM-4.9335Y-8.327+3.395
5Y-8.32710Y-5.204-3.123
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-3.742-0.277-3.465
MRQ-3.656-0.441-3.215
TTM-4.933-1.389-3.544
YOY-9.174-2.030-7.144
5Y-8.327-1.446-6.881
10Y-5.204-1.971-3.233
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Telo Genomics Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 8.28 means the investor is paying $8.28 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Telo Genomics Corp:

  • The EOD is 8.476. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.281. Based on the equity, the company is overpriced. -1
  • The TTM is 9.985. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.476MRQ8.281+0.195
MRQ8.281TTM9.985-1.704
TTM9.985YOY8.540+1.445
TTM9.9855Y7.993+1.992
5Y7.99310Y6.960+1.033
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD8.4761.897+6.579
MRQ8.2812.222+6.059
TTM9.9852.168+7.817
YOY8.5403.041+5.499
5Y7.9933.477+4.516
10Y6.9604.125+2.835
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Telo Genomics Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.011-0.001-91%-0.008-30%0.001-897%0.001-2156%
Book Value Per Share--0.0170.023-27%0.033-49%0.022-23%0.020-16%
Current Ratio--5.0688.413-40%28.033-82%16.757-70%11.239-55%
Debt To Asset Ratio--0.2100.146+44%0.072+194%0.730-71%0.803-74%
Debt To Equity Ratio--0.2670.175+53%0.078+242%0.147+81%0.331-19%
Dividend Per Share----0%-0%-0%-0%
Eps---0.009-0.008-8%-0.006-27%-0.005-45%-0.006-31%
Free Cash Flow Per Share---0.010-0.010+0%-0.008-18%-0.007-27%-0.007-27%
Free Cash Flow To Equity Per Share---0.0100.000-95%-0.007-24%0.000-99%0.000-99%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.906+10%
Intrinsic Value_10Y_max---0.564--------
Intrinsic Value_10Y_min---0.479--------
Intrinsic Value_1Y_max---0.034--------
Intrinsic Value_1Y_min---0.034--------
Intrinsic Value_3Y_max---0.120--------
Intrinsic Value_3Y_min---0.114--------
Intrinsic Value_5Y_max---0.226--------
Intrinsic Value_5Y_min---0.208--------
Market Cap10218709.243+2%9983390.62013531056.778-26%19146709.224-48%14537950.627-31%14066770.250-29%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio8.476+2%8.2819.985-17%8.540-3%7.993+4%6.960+19%
Pe Ratio-4.193-2%-4.096-6.155+50%-11.065+170%-12.224+198%-9.339+128%
Price Per Share0.143+2%0.1400.190-26%0.269-48%0.204-31%0.197-29%
Price To Free Cash Flow Ratio-3.742-2%-3.656-4.933+35%-9.174+151%-8.327+128%-5.204+42%
Price To Total Gains Ratio-13.196-2%-12.892-12.757-1%-36.479+183%-11.118-14%-9.715-25%
Quick Ratio--0.2420.273-11%0.469-48%0.358-32%0.289-16%
Return On Assets---0.399-0.341-15%-0.192-52%-0.219-45%-0.310-22%
Return On Equity---0.505-0.407-19%-0.208-59%-0.199-61%-0.229-55%
Total Gains Per Share---0.011-0.001-91%-0.008-30%0.001-897%0.001-2156%
Usd Book Value--1205551.0001653504.000-27%2342595.750-49%1562087.900-23%1432547.629-16%
Usd Book Value Change Per Share---0.011-0.001-91%-0.008-30%0.001-897%0.001-2156%
Usd Book Value Per Share--0.0170.023-27%0.033-49%0.022-23%0.020-16%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.009-0.008-8%-0.006-27%-0.005-45%-0.006-31%
Usd Free Cash Flow---682628.000-685468.250+0%-560771.500-18%-398852.100-42%-249282.563-63%
Usd Free Cash Flow Per Share---0.010-0.010+0%-0.008-18%-0.007-27%-0.007-27%
Usd Free Cash Flow To Equity Per Share---0.0100.000-95%-0.007-24%0.000-99%0.000-99%
Usd Market Cap10218709.243+2%9983390.62013531056.778-26%19146709.224-48%14537950.627-31%14066770.250-29%
Usd Price Per Share0.143+2%0.1400.190-26%0.269-48%0.204-31%0.197-29%
Usd Profit---609321.792-560597.462-8%-441996.970-27%-334981.467-45%-417890.107-31%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.011-0.001-91%-0.008-30%0.001-897%0.001-2156%
 EOD+5 -3MRQTTM+5 -24YOY+3 -265Y+2 -2710Y+4 -26

3.2. Fundamental Score

Let's check the fundamental score of Telo Genomics Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.193
Price to Book Ratio (EOD)Between0-18.476
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.242
Current Ratio (MRQ)Greater than15.068
Debt to Asset Ratio (MRQ)Less than10.210
Debt to Equity Ratio (MRQ)Less than10.267
Return on Equity (MRQ)Greater than0.15-0.505
Return on Assets (MRQ)Greater than0.05-0.399
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Telo Genomics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.263
Ma 20Greater thanMa 500.114
Ma 50Greater thanMa 1000.105
Ma 100Greater thanMa 2000.119
OpenGreater thanClose0.143
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,527
Total Liabilities321
Total Stockholder Equity1,206
 As reported
Total Liabilities 321
Total Stockholder Equity+ 1,206
Total Assets = 1,527

Assets

Total Assets1,527
Total Current Assets1,464
Long-term Assets63
Total Current Assets
Cash And Cash Equivalents 1,295
Net Receivables 70
Total Current Assets  (as reported)1,464
Total Current Assets  (calculated)1,365
+/- 99
Long-term Assets
Property Plant Equipment 47
Long-term Assets  (as reported)63
Long-term Assets  (calculated)47
+/- 16

Liabilities & Shareholders' Equity

Total Current Liabilities289
Long-term Liabilities33
Total Stockholder Equity1,206
Total Current Liabilities
Total Current Liabilities  (as reported)289
Total Current Liabilities  (calculated)0
+/- 289
Long-term Liabilities
Long term Debt 33
Long-term Liabilities  (as reported)33
Long-term Liabilities  (calculated)33
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)1,206
Total Stockholder Equity (calculated)0
+/- 1,206
Other
Capital Stock21,727
Common Stock Shares Outstanding 71,310
Net Invested Capital 1,238
Net Working Capital 1,175
Property Plant and Equipment Gross 945



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-06-30
> Total Assets 
471
696
3,524
4,920
3,991
2,401
1,644
2,286
1,751
430
424
312
322
263
440
1,713
1,244
1,169
1,001
1,829
2,164
3,839
3,930
3,740
3,319
2,833
2,259
1,625
980
2,926
2,201
1,527
1,5272,2012,9269801,6252,2592,8333,3193,7403,9303,8392,1641,8291,0011,1691,2441,7134402633223124244301,7512,2861,6442,4013,9914,9203,524696471
   > Total Current Assets 
0
0
0
2,883
2,170
1,696
1,005
1,742
1,212
167
180
86
105
83
276
1,566
1,113
1,037
885
1,728
2,070
3,761
3,867
3,691
3,284
2,787
2,186
1,553
888
2,843
2,126
1,464
1,4642,1262,8438881,5532,1862,7873,2843,6913,8673,7612,0701,7288851,0371,1131,56627683105861801671,2121,7421,0051,6962,1702,883000
       Cash And Cash Equivalents 
210
30
1,401
2,689
1,918
926
293
1,134
618
67
107
10
24
19
200
1,477
1,011
921
820
1,650
1,964
3,637
3,802
3,603
3,163
2,693
2,119
1,413
721
2,673
1,978
1,295
1,2951,9782,6737211,4132,1192,6933,1633,6033,8023,6371,9641,6508209211,0111,477200192410107676181,1342939261,9182,6891,40130210
       Net Receivables 
0
0
0
102
136
256
288
245
135
41
43
47
51
37
49
62
75
49
48
61
76
97
45
54
58
38
30
29
36
64
62
70
7062643629303858544597766148497562493751474341135245288256136102000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
217
180
164
147
131
131
116
100
94
78
62
49
35
47
73
73
92
83
75
63
637583927373473549627894100116131131147164180217000000000000
       Property Plant Equipment 
4
96
117
104
212
360
357
339
374
263
244
226
217
180
164
147
131
115
99
84
78
62
46
2
2
23
56
56
75
66
59
47
47596675565623224662788499115131147164180217226244263374339357360212104117964
       Intangible Assets 
237
503
507
479
478
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000478479507503237
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
217
180
164
147
131
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000131147164180217000000000000
> Total Liabilities 
233
854
510
237
480
683
695
943
822
744
999
1,050
1,165
1,308
1,623
496
260
393
282
228
201
154
206
78
88
230
207
141
164
313
221
321
32122131316414120723088782061542012282823932604961,6231,3081,1651,050999744822943695683480237510854233
   > Total Current Liabilities 
167
854
510
237
480
670
682
931
822
744
999
1,050
1,165
1,308
1,623
496
260
353
242
188
161
114
166
38
48
190
167
101
124
280
189
289
28918928012410116719048381661141611882423532604961,6231,3081,1651,050999744822931682670480237510854167
       Short-term Debt 
0
0
0
18
0
0
0
0
0
0
0
0
180
280
630
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000006302801800000000018000
       Short Long Term Debt 
0
0
0
18
0
0
0
0
0
0
0
0
180
280
630
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000006302801800000000018000
       Accounts payable 
70
587
461
213
480
667
679
928
781
633
423
474
985
1,028
993
449
237
301
222
173
161
102
138
38
48
190
167
101
0
0
0
0
000010116719048381381021611732223012374499931,02898547442363378192867966748021346158770
       Other Current Liabilities 
0
0
0
0
0
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000033300000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40
40
40
40
40
40
40
40
40
40
40
40
33
33
33
33333340404040404040404040404000000000000000000
       Other Liabilities 
0
0
0
0
0
13
14
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000012141300000
       Deferred Long Term Liability 
0
0
0
0
0
10
10
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000009101000000
> Total Stockholder Equity
238
0
3,015
4,683
3,511
1,718
948
1,343
930
-314
-575
-738
-843
-1,045
-1,184
1,217
984
775
718
1,600
1,963
3,686
3,724
3,662
3,232
2,603
2,051
1,484
816
2,613
1,980
1,206
1,2061,9802,6138161,4842,0512,6033,2323,6623,7243,6861,9631,6007187759841,217-1,184-1,045-843-738-575-3149301,3439481,7183,5114,6833,0150238
   Common Stock
381
1,133
6,234
7,384
7,738
8,024
8,316
8,996
11,575
11,441
11,741
11,741
11,741
11,741
11,741
14,303
14,278
14,326
14,407
15,562
16,186
18,234
18,719
19,106
19,106
19,106
19,106
19,166
0
0
0
0
000019,16619,10619,10619,10619,10618,71918,23416,18615,56214,40714,32614,27814,30311,74111,74111,74111,74111,74111,44111,5758,9968,3168,0247,7387,3846,2341,133381
   Retained Earnings Total Equity00000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
4,085
5,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000005,0004,0850000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-2,821
Operating Income-2,821-2,821
 
Operating Expense (+$)
Research Development1,364
Selling General Administrative1,457
Selling And Marketing Expenses-
Operating Expense2,8212,821
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-2,821
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-2,821-2,821
EBIT - interestExpense = 0
-2,821
-2,821
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--2,821
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-2,821
Tax Provision--
Net Income From Continuing Ops-2,821-2,821
Net Income-2,821
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Telo Genomics Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Telo Genomics Corp. The general trend of Telo Genomics Corp is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Telo Genomics Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Telo Genomics Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.161 < 0.192 < 0.192.

The bearish price targets are: 0.128 > 0.09 > 0.09.

Tweet this
Telo Genomics Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Telo Genomics Corp. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Telo Genomics Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Telo Genomics Corp. The current macd is 0.01140575.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Telo Genomics Corp price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Telo Genomics Corp. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Telo Genomics Corp price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Telo Genomics Corp Daily Moving Average Convergence/Divergence (MACD) ChartTelo Genomics Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Telo Genomics Corp. The current adx is 22.65.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Telo Genomics Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Telo Genomics Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Telo Genomics Corp. The current sar is 0.11363175.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Telo Genomics Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Telo Genomics Corp. The current rsi is 61.26. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Telo Genomics Corp Daily Relative Strength Index (RSI) ChartTelo Genomics Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Telo Genomics Corp. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Telo Genomics Corp price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Telo Genomics Corp Daily Stochastic Oscillator ChartTelo Genomics Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Telo Genomics Corp. The current cci is 77.16.

Telo Genomics Corp Daily Commodity Channel Index (CCI) ChartTelo Genomics Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Telo Genomics Corp. The current cmo is 22.54.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Telo Genomics Corp Daily Chande Momentum Oscillator (CMO) ChartTelo Genomics Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Telo Genomics Corp. The current willr is -24.47844228.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Telo Genomics Corp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Telo Genomics Corp Daily Williams %R ChartTelo Genomics Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Telo Genomics Corp.

Telo Genomics Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Telo Genomics Corp. The current atr is 0.01119498.

Telo Genomics Corp Daily Average True Range (ATR) ChartTelo Genomics Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Telo Genomics Corp. The current obv is -197,900.

Telo Genomics Corp Daily On-Balance Volume (OBV) ChartTelo Genomics Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Telo Genomics Corp. The current mfi is 54.91.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Telo Genomics Corp Daily Money Flow Index (MFI) ChartTelo Genomics Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Telo Genomics Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-30MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Telo Genomics Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Telo Genomics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.263
Ma 20Greater thanMa 500.114
Ma 50Greater thanMa 1000.105
Ma 100Greater thanMa 2000.119
OpenGreater thanClose0.143
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Telo Genomics Corp with someone you think should read this too:
  • Are you bullish or bearish on Telo Genomics Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Telo Genomics Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Telo Genomics Corp

I send you an email if I find something interesting about Telo Genomics Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Telo Genomics Corp.

Receive notifications about Telo Genomics Corp in your mailbox!